Zai Lab (ZLAB) Other Non Operating Income (2018 - 2026)
Zai Lab (ZLAB) posted Other Non Operating Income of $14.8 million for Q1 2026, up 53.24% sequentially from $9.7 million in Q4 2025, and up 2179.11% YoY from $651000.0 in Q1 2025.
Zai Lab (ZLAB) Other Non Operating Income (2018 - 2026) Analysis & Trends
Zai Lab has reported Other Non Operating Income for 9 years, with the latest figure at $14.8 million in Q1 2026.
- Quarterly Other Non Operating Income rose 2179.11% year-over-year to $14.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.7 million (up 301.07% YoY) and the FY2025 annual result came in at $19.6 million, up 229.42% from the prior year.
- Other Non Operating Income grew to $14.8 million in Q1 2026 per ZLAB's latest filing, from $9.7 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $16.6 million in Q4 2022 and troughed at -$40.4 million in Q3 2022.
- A 5-year average of -$3.0 million and a median of $4.9 million in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2026: Other Non Operating Income slumped 571.17% in 2022, then surged 2179.11% in 2026.
- Over 5 years, Other Non Operating Income stood at $16.6 million in 2022, then plunged by 31.14% to $11.5 million in 2023, then plunged by 304.26% to -$23.4 million in 2024, then soared by 141.34% to $9.7 million in 2025, then jumped by 53.24% to $14.8 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $14.8 million, $9.7 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.07 Mn |
| Mar 31, 2026 | 14.84 Mn |
| Dec 31, 2025 | 9.68 Mn |
| Sep 30, 2025 | 6.42 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 651,000.00 |
| Dec 31, 2024 | -23.42 Mn |
| Sep 30, 2024 | 14.46 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | 9.36 Mn |
| Dec 31, 2023 | 11.47 Mn |
| Sep 30, 2023 | 4.85 Mn |
| Jun 30, 2023 | -40.08 Mn |
| Mar 31, 2023 | 8.91 Mn |
| Dec 31, 2022 | 16.65 Mn |
| Sep 30, 2022 | -40.44 Mn |
| Jun 30, 2022 | -34.90 Mn |
| Mar 31, 2022 | -4.88 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | -13.58 Mn |